Interleukin-6 sequence variants are not associated with prostate cancer risk.
Sun J et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 2004